279 related articles for article (PubMed ID: 23912800)
1. Regulatory T cells in Behçet's disease: is there a correlation with disease activity? Does regulatory T cell type matter?
Gündüz E; Teke HU; Bilge NS; Cansu DU; Bal C; Korkmaz C; Gülbaş Z
Rheumatol Int; 2013 Dec; 33(12):3049-54. PubMed ID: 23912800
[TBL] [Abstract][Full Text] [Related]
2. CD4+CD25+ regulatory T cells in patients with Behçet's disease.
Hamzaoui K; Hamzaoui A; Houman H
Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S71-8. PubMed ID: 17067431
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet's disease and recurrent aphthous ulcerations.
Pekiner FN; Aytugar E; Demirel GY; Borahan MO
J Oral Pathol Med; 2012 Jan; 41(1):73-9. PubMed ID: 21736625
[TBL] [Abstract][Full Text] [Related]
4. Low expressions of PD-L1 and CTLA-4 by induced CD4
Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
[TBL] [Abstract][Full Text] [Related]
5. Induction of regulatory T cells by infliximab in Behcet's disease.
Sugita S; Yamada Y; Kaneko S; Horie S; Mochizuki M
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):476-84. PubMed ID: 20861484
[TBL] [Abstract][Full Text] [Related]
6. CD4(+) CD25(+) regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model.
Shim J; Lee ES; Park S; Bang D; Sohn S
Cytotherapy; 2011 Aug; 13(7):835-47. PubMed ID: 21506890
[TBL] [Abstract][Full Text] [Related]
7. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
[TBL] [Abstract][Full Text] [Related]
8. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
9. The relation of CD4
Kamal M; Gabr H; Anwar S; Bastawy S; Salah L
Lupus; 2022 Apr; 31(4):463-471. PubMed ID: 35249399
[TBL] [Abstract][Full Text] [Related]
10. Decreased levels of circulating CD4+CD25+Foxp3+ regulatory T cells in patients with primary antiphospholipid syndrome.
Dal Ben ER; do Prado CH; Baptista TS; Bauer ME; Staub HL
J Clin Immunol; 2013 May; 33(4):876-9. PubMed ID: 23354908
[TBL] [Abstract][Full Text] [Related]
11. Critical stoichiometric ratio of CD4(+) CD25(+) FoxP3(+) regulatory T cells and CD4(+) CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia.
Bhattacharya K; Chandra S; Mandal C
Immunology; 2014 May; 142(1):124-39. PubMed ID: 24354800
[TBL] [Abstract][Full Text] [Related]
12. 2-Gy whole-body irradiation significantly alters the balance of CD4+ CD25- T effector cells and CD4+ CD25+ Foxp3+ T regulatory cells in mice.
Qu Y; Zhang B; Liu S; Zhang A; Wu T; Zhao Y
Cell Mol Immunol; 2010 Nov; 7(6):419-27. PubMed ID: 20871628
[TBL] [Abstract][Full Text] [Related]
13. [The subpopulation CD4(+); CD25(+); Foxp3(+);/CD127(low/-); regulatory T cells in peripheral blood of HIV-infected patients correlated with disease progression].
Chen YL; Chen XR; Qin LX; Yang YF; Tang YM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1188-91. PubMed ID: 23127412
[TBL] [Abstract][Full Text] [Related]
14. sCTLA-4, CD4+CD25+Foxp3+ regulatory T cells in Behçet's disease patients.
Demir N; Ilhan F; Demir T; Godekmerdan A
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S116-7. PubMed ID: 23010434
[No Abstract] [Full Text] [Related]
15. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
[TBL] [Abstract][Full Text] [Related]
16. Subpopulations of regulatory T cells in rheumatoid arthritis, systemic lupus erythematosus, and Behcet's disease.
Kim JR; Chae JN; Kim SH; Ha JS
J Korean Med Sci; 2012 Sep; 27(9):1009-13. PubMed ID: 22969245
[TBL] [Abstract][Full Text] [Related]
17. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG
Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
[TBL] [Abstract][Full Text] [Related]
18. Elevated Circulating CD4
Hu X; Gu Y; Zhao S; Hua S; Jiang Y
Cancer Biother Radiopharm; 2019 Jun; 34(5):325-333. PubMed ID: 30925076
[No Abstract] [Full Text] [Related]
19. Role of regulatory CD4+CD25+ Foxp3 T cells in bronchial asthma in Egyptian children.
Bakr SI; Mahran MZ; Soliman DA
Egypt J Immunol; 2013; 20(2):29-38. PubMed ID: 24617045
[TBL] [Abstract][Full Text] [Related]
20. Aberrant peripheral blood CD4
Dehghani M; Kalani M; Golmoghaddam H; Ramzi M; Arandi N
Cancer Immunol Immunother; 2020 Sep; 69(9):1917-1928. PubMed ID: 32385519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
